Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study



van der Wouden, Cathelijne H, Bohringer, Stefan, Cecchin, Erika, Cheung, Ka-Chun, Lucia Davila-Fajardo, Cristina, Deneer, Vera HM, Dolzan, Vita, Ingelman-Sundberg, Magnus, Jonsson, Siv, Karlsson, Mats O
et al (show 17 more authors) (2020) Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study. Pharmacogenetics and Genomics, 30 (6). 131 - 144.

[img] Text
Generating evidence for precision medicine considerations made by the Ubiquitous Pharmacogenomics Consortium when designing .pdf - Published Version

Download (2MB) | Preview
Item Type: Article
Uncontrolled Keywords: adverse drug reactions, clinical implementation, genotyping, next-generation sequencing, pharmacogenomics, pharmacogenetics, pre-emptive, randomized controlled trial
Depositing User: Symplectic Admin
Date Deposited: 09 Sep 2020 08:34
Last Modified: 16 Oct 2021 11:12
DOI: 10.1097/FPC.0000000000000405
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3100411